Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

The immune system can typically ramp up the body's defenses to clear out an invading threat without issue. Glitches can ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Culver City-based Salt AI announced a research partnership with the Ellison Medical Institute in Sawtelle to develop a drug discovery ...

Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...

Nvidia (NASDAQ:NVDA) isn’t the first name that comes to mind in healthcare, but its far-reaching influence makes it a strong ...

Syntec Optics is providing critical optical manufacturing and sub-assembly processes to image laser light into our OEM's ...

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, precise, and non-invasive ...

A biotech firm deploys a humanoid robot to assist scientists, automate tasks, and enhance AI-driven drug discovery in its robotic lab.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Polypharmacology allows scientists to explore novel therapeutic purposes for existing drugs and opens new doors to treat ...

A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.